The long-term safety and efficacy of omalizumab, alongside promising phase 3 trial results that demonstrated the efficacy and ...

Experts highlight groundbreaking research presented at the American College of Cardiology Annual Scientific Session (ACC.25), which emphasized a shift toward more personalized, evidence-based ...

Oncology practices must address barriers related to technology and workflow to successfully implement a system to collect patient-reported outcomes, according to a viewpoint paper published in JAMA ...

Asthma and allergic diseases can be prevented through early primary and secondary interventions. The PANDA research group aims to identify, develop, and evaluate person-centered interventions for ...

The country’s rapid urban growth means it is suffering from numerous teething problems – how did authorities get it so wrong?

The RIFs at the CDC affect multiple divisions, including: ...

FDA aligned on plan to initiate parallel Phase 2 trials of rademikibart in patients with moderate-to-severe asthma or COPD experiencing an ...

The region's only certified pollen counter has retired, leaving it to the machines. The lack of reliable data remains a ...

ATHMA is more than just an HMIS—it is a powerful tool that empowers healthcare providers by automating critical hospital functions, reducing paperwork, and improving patient care quality.

Director Gopukiran Sadasivan challenged the Producers' Association's figures for his film ‘Aathma Saho,’ claiming it earned significantly more than reported. He asserted that misleading ...

Patients are dying because doctors are missing cancers on scans, an NHS watchdog has warned. More than 40 cases of errors in reading and reporting images that led to patient harm have been upheld ...

Set to take effect on April 4, it will apply to all medical conditions and surgical procedures under the current All Case Rates payment mechanism of PhilHealth for patients admitted to accredited ...